Emerging roles of ncRNAs regulating ABCC1 on chemotherapy resistance of cancer – a review

References

• Mandal R, Basu P. Cancer screening and early diagnosis in low and Middle income countries: current situation and future perspectives. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(12):1505–1512. doi: 10.1007/s00103-018-2833-9.
   PubMed Web of Science ®Google Scholar
• Cao W, Chen H-D, Yu Y-W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–791. doi: 10.1097/CM9.0000000000001474.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi: 10.3322/caac.21590.
   PubMed Web of Science ®Google Scholar
• Peng Y. Non-coding RNAs in human cancer. Semin Cancer Biol. 2021;75:1–2. doi: 10.1016/j.semcancer.2021.04.010.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22(12):3855–3864.
   PubMed Web of Science ®Google Scholar
• Haenisch S, Werk AN, Cascorbi I. MicroRNAs and their relevance to ABC transporters. Br J Clin Pharmacol. 2014;77(4):587–596. doi: 10.1111/bcp.12251.
   PubMed Web of Science ®Google Scholar
• Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233.
   PubMed Web of Science ®Google Scholar
• Liu X. ABC family transporters. Adv Exp Med Biol. 2019;1141:13–100.
   PubMed Web of Science ®Google Scholar
• Devault A, Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol. 1990;10(4):1652–1663. doi: 10.1128/MCB.10.4.1652.
   PubMed Web of Science ®Google Scholar
• He SM, Li R, Kanwar JR, et al. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr Med Chem. 2011;18(3):439–481. doi: 10.2174/092986711794839197.
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Khan EU, Rollinson CM, et al. Drug resistance in epilepsy: the role of the blood-brain barrier. Novartis Found Symp. 2002;243:38–47. discussion-53, 180–185.
   PubMedGoogle Scholar
• Lin X, Wu Z, Hu H, et al. Non-coding RNAs rewire cancer metabolism networks. Semin Cancer Biol. 2021;75:116–126. doi: 10.1016/j.semcancer.2020.12.019.
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(Spec No 1):R17–R29. doi: 10.1093/hmg/ddl046.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, et al. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347(2):159–166. doi: 10.1016/j.canlet.2014.03.013.
   PubMed Web of Science ®Google Scholar
• Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970;30(4):1174–1184.
   PubMed Web of Science ®Google Scholar
• Eckford PD, Sharom FJ. ABC efflux pump-based resistance to chemotherapy drugs. Chem Rev. 2009;109(7):2989–3011. doi: 10.1021/cr9000226.
   PubMed Web of Science ®Google Scholar
• Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol. 1992;8:67–113. doi: 10.1146/annurev.cb.08.110192.000435.
   PubMedGoogle Scholar
• Rees DC, Johnson E, Lewinson O. ABC transporters: the power to change. Nat Rev Mol Cell Biol. 2009;10(3):218–227. doi: 10.1038/nrm2646.
   PubMed Web of Science ®Google Scholar
• Ito K, Weigl KE, Deeley RG, et al. Mutation of proline residues in the NH(2)-terminal region of the multidrug resistance protein, MRP1 (ABCC1): effects on protein expression, membrane localization, and transport function. Biochim Biophys Acta. 2003;1615(1-2):103–114. doi: 10.1016/s0005-2736(03)00228-1.
   PubMed Web of Science ®Google Scholar
• Amawi H, Sim HM, Tiwari AK, et al. ABC transporter-mediated multidrug-resistant cancer. Adv Exp Med Biol. 2019;1141:549–580.
   PubMed Web of Science ®Google Scholar
• Oldham ML, Davidson AL, Chen J. Structural insights into ABC transporter mechanism. Curr Opin Struct Biol. 2008;18(6):726–733. doi: 10.1016/j.sbi.2008.09.007.
   PubMed Web of Science ®Google Scholar
• Colabufo NA, Berardi F, Contino M, et al. ABC pumps and their role in active drug transport. Curr Top Med Chem. 2009;9(2):119–129. doi: 10.2174/156802609787521553.
   PubMed Web of Science ®Google Scholar
• Seeger MA, van Veen HW. Molecular basis of multidrug transport by ABC transporters. Biochim Biophys Acta. 2009;1794(5):725–737. doi: 10.1016/j.bbapap.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Liu X. Transporter-mediated drug-drug interactions and their significance. Adv Exp Med Biol. 2019;1141:241–291.
   PubMed Web of Science ®Google Scholar
• Choi YH, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des. 2014;20(5):793–807. doi: 10.2174/138161282005140214165212.
   PubMed Web of Science ®Google Scholar
• Fletcher JI, Haber M, Henderson MJ, et al. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10(2):147–156. doi: 10.1038/nrc2789.
   PubMed Web of Science ®Google Scholar
• Cole SP. Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter. J Biol Chem. 2014;289(45):30880–30888. doi: 10.1074/jbc.R114.609248.
   PubMed Web of Science ®Google Scholar
• Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992;258(5088):1650–1654. doi: 10.1126/science.1360704.
   PubMed Web of Science ®Google Scholar
• Loe DW, Deeley RG, Cole SP. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer. 1996;32a(6):945–957. doi: 10.1016/0959-8049(96)00046-9.
   PubMed Web of Science ®Google Scholar
• Grant CE, Kurz EU, Cole SP, et al. Analysis of the intron-exon organization of the human multidrug-resistance protein gene (MRP) and alternative splicing of its mRNA. Genomics. 1997;45(2):368–378. doi: 10.1006/geno.1997.4950.
   PubMed Web of Science ®Google Scholar
• Conseil G, Deeley RG, Cole SP. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet Genomics. 2005;15(8):523–533. doi: 10.1097/01.fpc.0000167333.38528.ec.
   PubMed Web of Science ®Google Scholar
• Manciu L, Chang XB, Buyse F, et al. Intermediate structural states involved in MRP1-mediated drug transport. Role of glutathione. J Biol Chem. 2003;278(5):3347–3356. doi: 10.1074/jbc.M207963200.
   PubMed Web of Science ®Google Scholar
• Zaman GJ, Versantvoort CH, Smit JJ, et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res. 1993;53(8):1747–1750.
   PubMed Web of Science ®Google Scholar
• Giraud C, Manceau S, Treluyer JM. ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies. Expert Opin Drug Metab Toxicol. 2010;6(5):571–589. doi: 10.1517/17425251003601953.
   PubMed Web of Science ®Google Scholar
• Aye IL, Paxton JW, Evseenko DA, et al. Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes. Placenta. 2007;28(8-9):868–877. doi: 10.1016/j.placenta.2007.03.001.
   PubMed Web of Science ®Google Scholar
• Bosquillon C. Drug transporters in the lung–do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci. 2010;99(5):2240–2255. doi: 10.1002/jps.21995.
   PubMed Web of Science ®Google Scholar
• Liu X, Yue X, Chen S, et al. Significance of the expression of MRP1 and MRP2 in peripheral blood mononuclear cells of children with intractable epilepsy. Exp Ther Med. 2015;10(5):1784–1788. doi: 10.3892/etm.2015.2746.
   PubMed Web of Science ®Google Scholar
• Roelofsen H, Vos TA, Schippers IJ, et al. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology. 1997;112(2):511–521. doi: 10.1053/gast.1997.v112.pm9024305.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Finch RA, Lin ZP, et al. The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Res. 2001;61(4):1469–1476.
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005;204(3):216–237. doi: 10.1016/j.taap.2004.10.012.
   PubMed Web of Science ®Google Scholar
• Nunoya K, Grant CE, Zhang D, et al. Molecular cloning and pharmacological characterization of rat multidrug resistance protein 1 (mrp1). Drug Metab Dispos. 2003;31(8):1016–1026. doi: 10.1124/dmd.31.8.1016.
   PubMed Web of Science ®Google Scholar
• Yin J, Zhang J. Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011;36(10):927–938.
   PubMedGoogle Scholar
• Kunická T, Václavíková R, Hlaváč V, et al. Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer. PLoS One. 2014;9(7):e101740. doi: 10.1371/journal.pone.0101740.
   PubMed Web of Science ®Google Scholar
• Bruhn O, Lindsay M, Wiebel F, et al. Alternative polyadenylation of ABC transporters of the C-Family (ABCC1, ABCC2, ABCC3) and implications on posttranscriptional Micro-RNA regulation. Mol Pharmacol. 2020;97(2):112–122. doi: 10.1124/mol.119.116590.
   PubMed Web of Science ®Google Scholar
• Nasr R, Lorendeau D, Khonkarn R, et al. Molecular analysis of the massive GSH transport mechanism mediated by the human multidrug resistant protein 1/ABCC1. Sci Rep. 2020;10(1):7616. doi: 10.1038/s41598-020-64400-x.
   PubMed Web of Science ®Google Scholar
• Manciu L, Chang XB, Riordan JR, et al. Multidrug resistance protein MRP1 reconstituted into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes. Biochemistry. 2000;39(42):13026–13033. doi: 10.1021/bi001043v.
   PubMed Web of Science ®Google Scholar
• Hipfner DR, Deeley RG, Cole SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta. 1999;1461(2):359–376. doi: 10.1016/s0005-2736(99)00168-6.
   PubMed Web of Science ®Google Scholar
• Keppler D, Leier I, Jedlitschky G, et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. Chem Biol Interact. 1998;111-112:153–161. doi: 10.1016/s0009-2797(97)00158-0.
   PubMed Web of Science ®Google Scholar
• Kunická T, Souček P. Importance of ABCC1 for cancer therapy and prognosis. Drug Metab Rev. 2014;46(3):325–342. doi: 10.3109/03602532.2014.901348.
   PubMed Web of Science ®Google Scholar
• Wright MW, Bruford EA. Naming 'junk’: human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics. 2011;5(2):90–98. doi: 10.1186/1479-7364-5-2-90.
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi: 10.1016/s0092-8674(04)00045-5.
   PubMed Web of Science ®Google Scholar
• Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol. 2017;1509:1–10.
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207. doi: 10.1016/j.jaci.2017.08.034.
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101(9):2999–3004. doi: 10.1073/pnas.0307323101.
   PubMed Web of Science ®Google Scholar
• Qu B, Shen N. miRNAs in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci. 2015;16(5):9557–9572. doi: 10.3390/ijms16059557.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med. 2010;16(6):257–267. doi: 10.1016/j.molmed.2010.04.001.
   PubMed Web of Science ®Google Scholar
• Riquelme I, Letelier P, Riffo-Campos AL, et al. Emerging role of miRNAs in the drug resistance of gastric cancer. Int J Mol Sci. 2016;17(3):424. doi: 10.3390/ijms17030424.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang T, Guo R, et al. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1. J Drug Target. 2015;23(6):519–524. doi: 10.3109/1061186X.2015.1015536.
   PubMed Web of Science ®Google Scholar
• Li S, Yang J, Wang J, et al. Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1. Cell Biosci. 2018;8:9. doi: 10.1186/s13578-018-0209-3.
   PubMed Web of Science ®Google Scholar
• Chen M, Li D, Gong N, et al. miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs. Oncotarget. 2017;8(32):52983–52994. doi: 10.18632/oncotarget.17677.
   PubMedGoogle Scholar
• Li Y, Liu Y, Ren J, et al. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. J Neurooncol. 2018;138(3):499–508. doi: 10.1007/s11060-018-2835-3.
   PubMed Web of Science ®Google Scholar
• Jin Y, Wang H, Zhu Y, et al. miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells. Eur J Pharmacol. 2020;878:173105. doi: 10.1016/j.ejphar.2020.173105.
   PubMed Web of Science ®Google Scholar
• Pei K, Zhu JJ, Wang CE, et al. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1. Eur Rev Med Pharmacol Sci. 2016;20(22):4697–4704.
   PubMed Web of Science ®Google Scholar
• Liu H, Wu X, Huang J, et al. miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1. Int J Exp Pathol. 2015;96(4):240–247. doi: 10.1111/iep.12131.
   PubMed Web of Science ®Google Scholar
• Liu N, Zeng J, Zhang X, et al. Involvement of miR-200a in chemosensitivity regulation of ovarian cancer. Zhonghua Yi Xue Za Zhi. 2014;94(27):2148–2151.
   PubMedGoogle Scholar
• Lu L, Ju F, Zhao H, et al. MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1. Biotechnol Lett. 2015;37(12):2387–2394. doi: 10.1007/s10529-015-1941-y.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol. 2010;79(6):817–824. doi: 10.1016/j.bcp.2009.10.017.
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–1109. doi: 10.1016/j.bbagrm.2014.08.012.
   PubMed Web of Science ®Google Scholar
• Hermans-Beijnsberger S, van Bilsen M, Schroen B. Long non-coding RNAs in the failing heart and vasculature. Noncoding RNA Res. 2018;3(3):118–130. doi: 10.1016/j.ncrna.2018.04.002.
   PubMedGoogle Scholar
• Haddad G, Kölling M, Lorenzen JM. The hypoxic kidney: pathogenesis and noncoding RNA-based therapeutic strategies. Swiss Med Wkly. 2019;149:w14703. doi: 10.4414/smw.2019.14703.
   PubMed Web of Science ®Google Scholar
• Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45(11):604–611. doi: 10.5483/bmbrep.2012.45.11.227.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol. 2010;20(19):R858–61. doi: 10.1016/j.cub.2010.08.052.
   PubMed Web of Science ®Google Scholar
• Jeggari A, Marks DS, Larsson E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012;28(15):2062–2063. doi: 10.1093/bioinformatics/bts344.
   PubMed Web of Science ®Google Scholar
• Hu H, Yang L, Li L, et al. Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis. Biochem Biophys Res Commun. 2018;503(4):2400–2406. doi: 10.1016/j.bbrc.2018.06.168.
   PubMed Web of Science ®Google Scholar
• Huang H, Chen J, Ding CM, et al. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363. J Cell Mol Med. 2018;22(6):3238–3245. doi: 10.1111/jcmm.13605.
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Xiao-Long M, Chun-Lin Z. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget. 2017;8(42):71881–71893. doi: 10.18632/oncotarget.17985.
   PubMedGoogle Scholar
• Li B, Xie D, Zhang H. Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to gemcitabine in bladder cancer. Cancer Chemother Pharmacol. 2019;84(1):187–194. doi: 10.1007/s00280-019-03873-8.
   PubMed Web of Science ®Google Scholar
• Wu C, Su J, Long W, et al. LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR-134/myc/ABCC1 axis in glioma. J Cell Mol Med. 2020;24(20):12094–12106. doi: 10.1111/jcmm.15846.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang H, Tian Y, et al. LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p/ABCC1 axis. Anticancer Drugs. 2022;33(6):575–586. doi: 10.1097/CAD.0000000000001289.
   PubMed Web of Science ®Google Scholar
• Gao R, Fang C, Xu J, et al. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145. Arch Biochem Biophys. 2019;663:183–191. doi: 10.1016/j.abb.2019.01.005.
   PubMed Web of Science ®Google Scholar
• Shi C, Wang M. LINC01118 modulates paclitaxel resistance of epithelial ovarian cancer by regulating miR-134/ABCC1. Med Sci Monit. 2018;24:8831–8839. doi: 10.12659/MSM.910932.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–984. doi: 10.1038/cr.2015.82.
   PubMed Web of Science ®Google Scholar
• Greene J, Baird AM, Brady L, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38. doi: 10.3389/fmolb.2017.00038.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi: 10.1261/rna.035667.112.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461. doi: 10.1038/nbt.2890.
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20(12):1829–1842. doi: 10.1261/rna.047126.114.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi: 10.1038/nature11928.
   PubMed Web of Science ®Google Scholar
• Westholm JO, Miura P, Olson S, et al. Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation. Cell Rep. 2014;9(5):1966–1980. doi: 10.1016/j.celrep.2014.10.062.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. Embo J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–264. doi: 10.1038/nsmb.2959.
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi: 10.1016/j.molcel.2014.08.019.
   PubMed Web of Science ®Google Scholar
• Chen CY, Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 1995;268(5209):415–417. doi: 10.1126/science.7536344.
   PubMed Web of Science ®Google Scholar
• Zhao X, Cai Y, Xu J. Circular RNAs: biogenesis, mechanism, and function in human cancers. Int J Mol Sci. 2019;20(16):3926. doi: 10.3390/ijms20163926.
   PubMed Web of Science ®Google Scholar
• Braicu C, Zimta AA, Harangus A, et al. The function of non-coding RNAs in lung cancer tumorigenesis. Cancers. 2019;11(5):605. doi: 10.3390/cancers11050605.
   PubMed Web of Science ®Google Scholar
• Zhao S, Xu F, Wang JY, et al. L. Circular RNA circ-CD44 regulates chemotherapy resistance by targeting the miR-330-5p/ABCC1 axis in colorectal cancer cells. Histol Histopathol. 2022;15:18516.
   Google Scholar
• Liu L, Zhang Q, Peng H. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer. J Chemother. 2023;35(1):39–52. doi: 10.1080/1120009X.2022.2043515.
   PubMed Web of Science ®Google Scholar
• Shao N, Song L, Sun X. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. Mol Cell Biochem. 2021;476(6):2253–2267. doi: 10.1007/s11010-021-04083-8.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi: 10.1038/nature11993.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang H, Jiang H, et al. Circular RNAcirc_0076305 promotes cisplatin (DDP) resistance of non-small cell lung cancer cells by regulating ABCC1 through miR-186-5p. Cancer Biother Radiopharm. 2023;38(5):293–304. Aug 2. doi: 10.1089/cbr.2020.4153.
   PubMed Web of Science ®Google Scholar
• Chu D, Li P, Li Y, et al. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis. Thorac Cancer. 2021;12(21):2894–2906. doi: 10.1111/1759-7714.14150.
   PubMed Web of Science ®Google Scholar
• Zheng F, Xu R. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. Biomed Pharmacother. 2020;124:109828. doi: 10.1016/j.biopha.2020.109828.
   PubMed Web of Science ®Google Scholar